Black Jeffrey G. — SEC insider filings
SEC reporting owner CIK 1449439. 23 insider filings on record with FilingPulse; latest filed 2026-09-02.
Transaction summary — filings shown
Covers all 23 filings on record, filed 2020-08-06 to 2026-09-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 7 legs across 4 filings — 173,282 shares, $707,876 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 7 legs across 7 filings — 88,593 shares, $955,705 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 28.
- Largest priced transaction: sale of 25,000 shares @ $16.28 ($407,000) in Alphatec Holdings, Inc., filed 2021-02-18.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Alphatec Holdings, Inc. (ATEC) | EVP & CFO | 4 | — | 4 legs · 45,929 sh · $600,843 | — |
| Apollo Endosurgery, Inc. (APEN) | Chief Financial Officer | 6 | 4 legs · 65,000 sh · $447,850 | — | 10 |
| EXAGEN INC. (XGN) | Chief Financial Officer | 7 | 1 leg · 22,298 sh · $66,448 | 3 legs · 42,664 sh · $354,862 | 7 |
| STANDARD BIOTOOLS INC. (LAB) | SVP & Chief Financial Officer | 6 | 2 legs · 85,984 sh · $193,578 | — | 11 |
Insider filings — Black Jeffrey G.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-02 | 4 | EXAGEN INC. (XGN) | Sale (S): 20,614 @ $7.22 · Grant/award (A): 1,571 @ $3.02 | EDGAR |
| 2026-03-16 | 4 | EXAGEN INC. (XGN) | Grant/award (A): 75,000 @ $3.16 · Grant/award (A): 1,511 @ $3.08 · Grant/award (A): 50,000 (derivative) @ $3.16 | EDGAR |
| 2026-02-25 | 4 | EXAGEN INC. (XGN) | Sale (S): 1,584 @ $3.61 | EDGAR |
| 2025-09-04 | 4 | EXAGEN INC. (XGN) | Sale (S): 20,466 @ $9.79 | EDGAR |
| 2025-02-25 | 4 | EXAGEN INC. (XGN) | Grant/award (A): 15,000 @ $0 · Grant/award (A): 10,000 (derivative) @ $3.58 | EDGAR |
| 2024-11-19 | 4 | EXAGEN INC. (XGN) | Purchase (P): 22,298 @ $2.98 | EDGAR |
| 2024-09-05 | 4 | STANDARD BIOTOOLS INC. (LAB) | Tax withholding (F): 6,690 @ $1.91 | EDGAR |
| 2024-09-04 | 4 | EXAGEN INC. (XGN) | Grant/award (A): 225,000 @ $0 | EDGAR |
| 2024-08-19 | 4 | STANDARD BIOTOOLS INC. (LAB) | Option exercise (M): 13,157 @ $0 · Tax withholding (F): 4,695 @ $1.55 · Option exercise (M): 13,157 (derivative) @ $0 | EDGAR |
| 2024-05-21 | 4 | STANDARD BIOTOOLS INC. (LAB) | Grant/award (A): 300,000 @ $0 · Grant/award (A): 400,000 (derivative) @ $0 | EDGAR |
| 2024-05-16 | 4 | STANDARD BIOTOOLS INC. (LAB) | Option exercise (M): 52,631 @ $0 · Tax withholding (F): 18,779 @ $2.54 · Option exercise (M): 52,631 (derivative) @ $0 | EDGAR |
| 2023-05-22 | 4 | STANDARD BIOTOOLS INC. (LAB) | Purchase (P): 43,492 @ $2.22 · Purchase (P): 42,492 @ $2.29 | EDGAR |
| 2023-05-17 | 4 | STANDARD BIOTOOLS INC. (LAB) | Grant/award (A): 210,526 (derivative) @ $0 · Grant/award (A): 400,000 (derivative) @ $0 | EDGAR |
| 2023-04-04 | 4 | Apollo Endosurgery, Inc. (APEN) | Disposition to issuer (D): 335,330 · Disposition to issuer (D): 150,000 (derivative) · Disposition to issuer (D): 120,834 (derivative) | EDGAR |
| 2022-11-04 | 4 | Apollo Endosurgery, Inc. (APEN) | Tax withholding (F): 15,060 @ $6.46 | EDGAR |
| 2022-08-05 | 4 | Apollo Endosurgery, Inc. (APEN) | Tax withholding (F): 6,190 @ $6.46 | EDGAR |
| 2022-06-16 | 4 | Apollo Endosurgery, Inc. (APEN) | Grant/award (A): 88,900 @ $0 · Grant/award (A): 120,834 (derivative) @ $0 | EDGAR |
| 2022-03-01 | 4 | Apollo Endosurgery, Inc. (APEN) | Purchase (P): 15,000 @ $5.48 · Purchase (P): 15,000 @ $5.66 · Purchase (P): 10,000 @ $6.20 | EDGAR |
| 2021-08-11 | 4 | Apollo Endosurgery, Inc. (APEN) | Purchase (P): 25,000 @ $8.75 · Grant/award (A): 120,000 @ $0 · Grant/award (A): 80,000 @ $0 · Grant/award (A): 150,000 (derivative) @ $8.69 | EDGAR |
| 2021-03-10 | 4 | Alphatec Holdings, Inc. (ATEC) | Sale (S): 7,000 @ $16.69 | EDGAR |
| 2021-02-18 | 4 | Alphatec Holdings, Inc. (ATEC) | Sale (S): 25,000 @ $16.28 | EDGAR |
| 2020-08-13 | 4 | Alphatec Holdings, Inc. (ATEC) | Sale (S): 5,000 @ $6.42 | EDGAR |
| 2020-08-06 | 4 | Alphatec Holdings, Inc. (ATEC) | Sale (S): 8,929 @ $5.03 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-08-06 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1449439 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs